Literature DB >> 22767403

AMP-activated protein kinase in the control of cardiac metabolism and remodeling.

Sandrine Horman1, Christophe Beauloye, Jean-Louis Vanoverschelde, Luc Bertrand.   

Abstract

The AMP-activated protein kinase (AMPK) can be firstly considered as a cellular fuel gauge. AMPK rapidly senses energy deprivation and orchestrates a metabolic response to maintain an acceptable energy level required for cell survival under such adverse condition. Its protective role during myocardial ischemia has been deeply documented. More recently, it has been shown that the role of AMPK extends to several nonmetabolic effects related to other cardiac pathologies comprising diabetic cardiomyopathy, cardiac hypertrophy, and heart failure. Here, we briefly review the different roles played by AMPK in the control of cardiac metabolism and function under normal and pathological conditions. The potential cardioprotective actions of AMPK and the relative importance of its energetic and nonmetabolic effects in these mechanisms are deeply discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767403     DOI: 10.1007/s11897-012-0102-z

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  96 in total

1.  Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors:  F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

2.  LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis.

Authors:  Koji Ohashi; Noriyuki Ouchi; Akiko Higuchi; Reuben J Shaw; Kenneth Walsh
Journal:  J Biol Chem       Date:  2010-05-19       Impact factor: 5.157

3.  AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol.

Authors:  Kirk M Habegger; Nolan J Hoffman; Colin M Ridenour; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

4.  Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.

Authors:  Ralph Knöll; Guido Iaccarino; Guido Tarone; Denise Hilfiker-Kleiner; Johann Bauersachs; Adelino F Leite-Moreira; Peter H Sugden; Jean-Luc Balligand
Journal:  Eur J Heart Fail       Date:  2011-06-27       Impact factor: 15.534

5.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

Review 6.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

7.  AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase.

Authors:  Sandrine Horman; Nicole Morel; Didier Vertommen; Nusrat Hussain; Dietbert Neumann; Christophe Beauloye; Nicole El Najjar; Christelle Forcet; Benoit Viollet; Michael P Walsh; Louis Hue; Mark H Rider
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

8.  Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.

Authors:  Yanqiu Xing; Nicolas Musi; Nobuharu Fujii; Liqun Zou; Ivan Luptak; Michael F Hirshman; Laurie J Goodyear; Rong Tian
Journal:  J Biol Chem       Date:  2003-05-23       Impact factor: 5.157

9.  Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes.

Authors:  Ulrike Krause; Luc Bertrand; Louis Hue
Journal:  Eur J Biochem       Date:  2002-08

10.  Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.

Authors:  Yiqun Wang; Yu Huang; Karen S L Lam; Yiming Li; Wing Tak Wong; Hongying Ye; Chi-Wai Lau; Paul M Vanhoutte; Aimin Xu
Journal:  Cardiovasc Res       Date:  2009-02-27       Impact factor: 10.787

View more
  26 in total

1.  Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease.

Authors:  Maxime Vergouts; Claudia Marinangeli; Caroline Ingelbrecht; Geraldine Genard; Olivier Schakman; Anthony Sternotte; André-Guilhem Calas; Emmanuel Hermans
Journal:  Metab Brain Dis       Date:  2015-07-09       Impact factor: 3.584

Review 2.  Genetic Infiltrative Cardiomyopathies.

Authors:  Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

3.  A functional role for AMPK in female fertility and endometrial regeneration.

Authors:  Melissa L McCallum; Cindy A Pru; Andrea R Smith; Nicole C Kelp; Marc Foretz; Benoit Viollet; Min Du; James K Pru
Journal:  Reproduction       Date:  2018-12       Impact factor: 3.906

Review 4.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 5.  Molecular basis of physiological heart growth: fundamental concepts and new players.

Authors:  Marjorie Maillet; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01       Impact factor: 94.444

Review 6.  Heart Failure in Type 2 Diabetes Mellitus.

Authors:  Helena C Kenny; E Dale Abel
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

7.  Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662.

Authors:  Serge Ducommun; Rebecca J Ford; Laurent Bultot; Maria Deak; Luc Bertrand; Bruce E Kemp; Gregory R Steinberg; Kei Sakamoto
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-14       Impact factor: 4.310

8.  AMPK is required for uterine receptivity and normal responses to steroid hormones.

Authors:  Richard M Griffiths; Cindy A Pru; Susanta K Behura; Andrea R Cronrath; Melissa L McCallum; Nicole C Kelp; Wipawee Winuthayanon; Thomas E Spencer; James K Pru
Journal:  Reproduction       Date:  2020-05       Impact factor: 3.906

Review 9.  Role of purines in regulation of metabolic reprogramming.

Authors:  Zhenwei Tang; Wenrui Ye; Haotian Chen; Xinwei Kuang; Jia Guo; Minmin Xiang; Cong Peng; Xiang Chen; Hong Liu
Journal:  Purinergic Signal       Date:  2019-09-06       Impact factor: 3.765

Review 10.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.